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Cartxmll(Gll)acetate hasbeeninttoducedfor 
the noninvasive measurements of myocardial 
oxygen consumption. This study was designed to 
assessre~onalGllacetateclearance inp 
tients with acute myocaulial infarction. Thirtyone 
patients were studied within 8 days of acute 
myocardial infarction. C-11 acetate washoutrate 
constants were significantly lower in the infarct 
territory than in the remote myocardium (p 
<O.OOS). The scintigraphic measurements corre- 
lated with heart rate-blood pressure product in 
the remote as well as infarct areas (0.52 and 
0.48, respectively). There was no significant colt 
relation to left ventricular ejection fraction. Gll 
washout rates were significantly affected by j3- 
receptor therapy as assessed by multiple regrew 
sion analysis. Thus, Gll acetate kinetics allow 
noninvasive characterization of regional myocar- 
dial oxygen demand, which may be useful in a~ 
sessing the extent of myocardial injury and my* 
cardial oxygen demand of remote myocaidium. 
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P ositron emission tomographic imaging (PET) of the heart using radiolabeled fatty acids and glu- cose analogs has provided unique and clinicallly 
useful means of assessing global and regional myo- 
cardial metabolism in health and disease states.lg The 
ability of the metabolic tracer carbon-11 (C-11) acetate to 
noninvasively depict regional myocardkl oxygen con- 
sumption and its relative independence of substrate 
availability has been extensively validated in both ani- 
mal@ and human studies.5,9J0 This study therefore ex- 
plores the use of regional myocardial C-11 washout-rate 
constants measured by dynamic PET imaging as a 
means of assessing quantitative regional myocardial oxy- 
gen consumption in patients who have recently had an 
acute myocardial infarction. The relation between this 
technique and other traditional methods of indirectly asseiss- 
ing myocardial oxygen consumption is also explored. 
METHODS 
Patient group: Thirty-one patients, 26 men and1 5 
women, aged 24 to 79 years (mean 57 + 14), were en- 
rolled in this protocol. Twenty-four patients were stud- 
ied within 4 days and the remaining patients within 8 
days of acute myocardial infarction. Each was also en- 
rolled in an ongoing thrombolysis and angioplasty 
(Thrombolysis in Acute Myocardial Infarction trial) re- 
search protocol. Thus, they received either recombinant 
tissue-type plasminogen activator therapy or coronary 
angioplasty of the culprit artery on hospital presentation. 
On the basis of their electrocardiographic abnormalities, 
18 patients had an acute anterior infarction, whereas the 
remainder had an inferior or lateral myocardial infarct. 
All had a significant cardiac enzyme increase consistent 
with the diagnosis of acute myocardial infarction. 
For comparison with normal data, 6 healthy male 
volunteers aged 25 to 28 years, each with a low-pretest 
likelihood for cardiac disease and a normal resting elec- 
trocardiogram, underwent an identical PET imaging 
study. 
The study protocols were approved by the ethics and 
radioactive drug research committees of the University 
of Michigan, and each volunteer or patient signed an 
informed consent form approved by those committees. 
Study protocol: Dynamic PET imaging with C-11 
acetate was performed in each subject. Heart rate and 
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cuffed blood pressure measurements to be used for sub- 
sequent rate-pressure product calculations were record- 
ed during PET data acquisition as were the cardioactive 
medications that each patient was taking at that time. 
Where possible, patients who had a myocardial in- 
farction also underwent an electrocardiogram-gated car- 
diac blood pool scan within 5 days of presentation, a 
requirement of the Thrombolysis in Acute Myocardial 
Infarction trial study protocol. Thus, indexes of left ven- 
tricular function obtained close to the time of the PET 
study were available for analysis in most patients (26 of 
31). 
Positmnemission~ . PET was performed 
using a Siemens 931 whole body tomograph. This tomo- 
graph has 8 rings, each with 512 detectors and is capa- 
ble of acquiring 15 simultaneous tramaxial planes of data. 
The carbon-11 acetate was synthesized by a modification 
of the method previously described by Pike et al4 
An initial lo-minute transmission PET study was 
performed using a ring source of germanium-68/galli- 
urn-68. These data were used to ensure correct position- 
ing of the heart in the center of the field of view and 
for subsequent tissue attenuation correction. Dynamic 
PET data acquisition was then started as 20 mCi of C- 
11 acetate was injected intravenously as a bolus over 15 
seconds. Seventeen to 20 frames of dynamic PET data 
were collected for 30 minutes, with 7 sets of positron 
tomographic images each being collected for 30 sec- 
onds, followed by 6 to 9 sets for 60 seconds each, 4 for 
120 seconds each and 1 data set each for 180 and 300 
seconds. 
Image analysis: Using software developed in our 
laboratory, each frame of the dynamic PET study was 
reconstructed into 17 transaxial planes. In patients with 
an inferior myocardial infarction, these data were also 
reformatted into 12 to 16 cardiac short-axis planes span- 
ning the left ventricle from apex to base. A midleft ven- 
tricular slice was then chosen from inspection of an 
early frame of the dynamic PET study (2 to 4 minutes). 
At this time, C-11 acetate has been essentially cleared 
from the cardiac blood pool and any myocardial C-11 
activity seen predominantly reflects regional myocardial 
blood flow.‘l,12 
In the patients with myocardial infarction, 2 regions 
of interest were then delined by the operator. The lirst, 
representing normal myocardium remote from the infarct 
region, was chosen in a myocardial segment with appar- 
ently normal early C-11 uptake. The second region of 
interest, representing the infarcted or ischemic zone, was 
drawn over an area of reduced early C-11 uptake. It too 
was deliberately made as large as feasible without 
including transition areas between low “flow” and nor- 
mal “flow.” In normal subjects, only 1 large region of 
interest over the entire left ventricular region was drawn. 
Using these regions of interest, time-activity curves 
were generated from the dynamic PET data set. The 
descending limb of each curve underwent a monoexpo- 
nential curve-fitting procedure to the initial linear por- 
tion of the hrst exponential using the least-squares fit 
method. The earliest data point chosen for curve fitting 
was based on the earliest frame of data that demon- 
strated substantial clearance of C-11 activity from the 
blood pool. The monoexponential curve-fitting algorithm 
was chosen rather than the biexponential curve-fitting 
procedure because of the relatively short data acquisition 
procedure possible in many of these patients and the 
lindings in other laboratories, suggesting that the corre- 
lation with myocardial oxygen consumption is only 
marginally affected using me simpler and reproducible 
monoexponential fit than the more elaborate curve-fitting 
approaches8J3 C-ll washout-rate constants (k/min) were 
then generated (rate constant F/min] = 0.693/ washout 
halftime [per minute]). 
Statistid analysis: Values are given as mean f 
SD. For statistical analysis, comparison of groups was 
by analysis of variance followed by Bonferroni’s mod- 
itied t test when signiticant intergroup differences were 
indicated by analysis of variance or multiple regression 
analysis. Paired samples were compared using Student’s 
t test for paired data. Statistical signiticance was indi- 
cated by p values 50.05. 
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FlGURE 1. A representative sequential series of images showing regional carbon-11 (C-11) activity obtained from the mid- 
transaxial myocadial plane acquired over 30 minutes in a patient with a recent anterior myocardial infarct. Note the 
reduced initial uptake and then prolonged washout in the infarct zone. The timdivity curves are ussd for subsequent 
mono+xponsntial curve Rtting. Note ths much lower amplitude and the somewhat different shape to the normal washout 
curve. PET q posibon emission tomography. 
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RESULTS 
poatronemission~ . Each dynamic PET 
study resulted in high-quality images that were all emi- 
nently suitable for analysis. Figures la and b show a typ- 
ical series of temporal midventricular images in a pa- 
tient with an anterior myocardial infarction, and Figure 
lb shows the time-activity curves generated from re- 
gions of interest placed over normal remote and isch- 
emically damaged myocardium. In this case, the myo- 
car-dial washout-rate constants were O.O6/min in the nor- 
mal region and prolonged to O.O3/min in the ischemic 
zone. 
Carbon-11 wadroutrate constants in normal vol- 
unteers and infamt poltients: A comparison between 
the mean C-11 myocardial washout-rate constants in the 
normal volunteers and in the remote normal, ischemic 
or infarcted myocardium of the patients is shown in Fig- 
ure 2. Washout-rate constants in the infarct or ischemic 
region of patients with inferior or lateral infarcts (0.0134 
5 0.01 k/mm) were signiftcantly higher (p <0.04) than 
those in corresponding regions of patients with anterior 
infarcts (0.025 + 0.01 k/nun). This may reflect more 
extensive myocardial damage in left anterior descending 
artery infarcts, allowing better delineation between in- 
farcted and ischemic tissue. The washout-rate constants 
of the infarcted/ischemic regions in patients with either 
anterior or other infarcts were significantly lower (p 
<0.008) than those in normal volunteers (0.051 + 0.006 
k/mm). Washout-rate constants of the infarcted/ischemic 
regions were also substantially lower than those for the 
remote myocardium in individual patients with either 
anterior (0.060 + 0.017 k/n&, t statistic = -11.03, p 
<O.OOl) or other (0.065 f 0.011 k/min, t statistic = -7.3; 
p <O.OOl) infarcts. These findings are in keeping with 
FlGURE 2. lhe indiidual cartxn+ll (Gil) 
acetate waskouhate constants obtained 
from ths normal myocardium of the volu* 
teem (Vols) are compared with those 
obtained tiwm the remote normal and 
ischemic/infarcted regions in patients with 
anterior or nonanterior infarcts (as defined 
from the electrocardiogram). Note that there 
is a si@Micant difference in mean k/min 
between the remote normal myecardium and 
the corresponding anterior or nonanterior 
infarct ischemic/infarct zone (p cO.001). lhe 
difference between the mean k/min of the 
normal volunteer and that of the normal 
remote myocardium of patients with interior 
infarcts also just reached statistical si@ti- 
canca (p cO.04). MI = myocardial infarction. 
RGURE 3. The relation between ratepres 
sure products and carbeull w-e 
constants (k/min) of patients with anterior 
and interior (OTRER) myocardial infarcts (Ml) 
in the remote normal (top) and ischsmic/ 
infarct (betteer~ regions are shown. Note the 
reasonable cerretations in both ischemic/ 
infarcted and normal myocardium, and the 
widescatterofdataoverawiderangeot 
rateqwessure proclucts vatues. 
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reduced oxidative metabolism in the infarcted/ischemic 
region. However, the relatively large standard deviations 
observed suggest heterogeneity of metabolism within 
infarct-stunned or ischemic myocardium. 
Interestingly, the C-11 myocardial washout-rate con- 
stants were slower in the normal volunteers than in the 
remote normal regions of the infarct patients, with 
patients in the subgroup without anterior infarcts just 
reaching statistical signiticance (p <O&I). This tinding 
may reflect the differing hemodynamic state of the sub- 
groups. The mean rate-pressure products in the volun- 
teers (6,420 + 912) were significantly lower (p ~0.03) 
than in either infarct group (8,124 f 1,260 in the group 
with inferior infarcts, and 8,167 + 1,601 in patients an- 
terior infarcts). 
Interobserver lmidJilii of calmldl waebut 
measurements: To detine possible methodologic fac- 
tors affecting the scintigraphic measurements in infarct 
patients, we assessed the interobserver variability of C- 
11 acetate washout kinetics in the infarct as well as 
remote myocardium of 18 randomly selected patients of 
the study group. The washout-rate constants in remote 
myocardium determined by 2 observers were not signif- 
icantly different (0.062 Z!I 0.013 vs 0.064 + 0.013 k/min) 
and correlated with an r value of 0.91 (SEE 0.005). In 
infarcted regions, the values were 0.028 I!Z 0.04 k/mm 
and 0.029 f 0.012 k/min with an r value of 0.79 (SEE 
0.007). 
Relation of heart rate-blood pressure product 
and carbo~~ll washoutrate constank As expected, 
regional myocardial C-11 washout-rate constants in the 
normal remote myocardium in patients who had a 
myocardial infarction were significantly correlated (p 
<0.003) with the rate-pressure product at the time of the 
study. The individual points are shown in Figure 3 (top). 
However, the correlation coefficient was only 0.52 (SEE 
of 1,225 rate-pressure product units) despite a wide 
range of rate-pressure products and washout-rate con- 
stants. Thus, in individual patients with myocardial 
infarction, the rate-pressure product is only a fan indi- 
cator of regional myocardial oxygen use in the nonis- 
chemic myocardium remote from the infarct zone. 
There was also a significant correlation between the 
rate-pressure product and regional washout rates (Figure 
3, bottom) in the infarcted or ischemic zone (r = 0.48; 
SEE 1,205; p 50.02). This suggests that variations in left 
ventricular loading conditions also influence myocardial 
oxygen consumption in the ischemic zone. 
Commson of left ventricular ejection ikaction 
and carbomll washout-rate constants: Left ventric- 
ular ejection fraction is an indirect measure of infarct 
size and, thus, may detine the metabolic demand of sur- 
viving myocardium. Consequently, its relation with the 
C-11 washout-rate constant of the remote normal myo- 
cardium was examined. The results of this analysis are 
shown in Figure 4. There was no sign&ant correlation 
seen (r = 0.1, F ratio: 0.02, p 9.9) despite a wide range 
of ejection fractions and washout-rate constants. There 
was also no relation between rate-pressure product and 
left ventricular ejection fraction (r = 0.16, F ratio: 0.636, 
p >0.5). The lack of relationship may be due to the rel- 
ative insensitivity of left ventricular ejection fraction 
measurement o changes in loading conditions caused by 
the hemodynamic effects of different drug therapies that 
were given to individual patients. 
Other medications such as calcium antagonists, ni- 
trates and angiotensin-converting enzymes had no ap- 
parent independent effect on the remote myocardial oxy- 
gen consumption using univariate or multivariate analy- 
sis, Myocardial oxygen consumption was 0.067 f 
O.lO/min with calcium antagonists versus 0.060 Z!Z 
17/min without treatment (t =-1.234, p = 0.2). For 
nitrates, the average C-11 clearance-rate constant was 
0.061 Z!I 0.016 with versus 0.064 f 0.010 without treat- 
ment (t = 0.066; p = 0.517). For angiotensin inhibitors, it 
was 0.066 f O.Oll/min with versus 0.061 IL 15/min with- 
out treatment (t = 0.83, p = 0.41). 
Effect of medication on ~&nal catbomll 
washouhate constants: Because medical therapy var- 
ied from patient to patient, its effect on regional C-11 
washout-rate constants could only be assessed for 
groups of patients taking a given medication. The effect 
of B blockade; which was current therapy for 19 of 31 
patients at the time of the PET study, was most inter- 
esting. This medication is known to reduce myocardial 
oxygen consumption. Figure 5 shows that B blockade 
had little effect on myocardial C-11 washout kinetics in 
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FlGURE 4. The lack of -elation between the left ventricv FlGURE 5. Carbon-11 clearancerate constants in the remote 
lar (LV) ejection fraction+ and washoutiate constants in the myocardium were significantly lower in patients receiving 
-1 remote myocardium in patients with anterior and pmceptor bkxkem than in those not receiving this mediw 
nonanterior (OTHER) my-al infarcts (Ml) is demonstrat- tion. A similar but not statistically significant trend was 
aby--plot noted for the infanztfischemic zone. 
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TABLE I Multiple Regression Analysis: Independent Predictors 
of Regional Myocardial Oxygen Consumption 
Normal Infarcted 
Myocardium Myocardium 
Independent t Signif- t Signif- 
Variables Statistic icance Statistic icance 
Rate-pressure product 2.4 0.025 3.1 0.005 
p blockade -2.5 0.02 -1.6 0.13 
Constant 1.84 0.08 -0.3 0.8 
Nitrates 0.54 0.46 0.1 0.9 
Ace inhibitors -0.4 0.56 0.3 0.7 
Digoxin -0.47 0.64 -0.8 0.5 
Calcium antagonist -0.47 0.65 -1.6 0.13 
LV ejection fraction -0.34 0.74 0.8 0.4 
Dependent variable carbon-l 1 washout-rate constant (k/min) 
LV = left ventricular. 
the infarct/ischemic region in patients with (0.029 f 
0.011 k/min) and without (0.031 + 0.011 k/min) therapy. 
In contrast, the C-11 washout-rate constants in the 
remote regions of normal myocardium were significant- 
ly lower (p cO.03) in patients with (0.057 f 0.014 k/min) 
than without (0.070 + 0.011 k/min) p-receptor blockers 
(Figure 5). This difference was not mirrored by similar 
concomitant differences in mean rate-pressure product 
(8,042 * 1,506 with vs 8,320 f 1,396 without P-block- 
er therapy; p = 0.6) and left ventricular ejection frac- 
tions (40 + 14% with vs 42 f 18% without p-blocker 
therapy; p = 0.8). This apparently independent effect of 
p blockade on regional C-11 acetate clearance in the 
nonischemic myocardium was confirmed on multiple 
regression analysis (Table I). In the ischemic regions, 
this independent effect failed to reach significance. 
However, a similar trend was seen for the effects of p- 
receptor blockers in the ischemic zone. The apparent dif- 
ferential effect of p-receptor blockers may be due more 
to technical difficulties with stability of curve fitting in 
the regions of infarcted/ischemic myocardium than to a 
true phenomenon. 
Correlation of cakimdl washout rates and clin- 
ical parameters: C-11 washout-rate constants in the 
infarcted and remote myocardium were correlated with 
clinical parameters (Tables II and IlI). Among the 
parameters tested by multiple regression analysis, the 
time period between onset of symptoms to open infarct 
artery and location of infarct signScantly affected the C- 
11 acetate washout-rate constants in the infarct territory. 
In addition, C-11 acetate kinetics were significantly relat- 
ed to the product of heart rate and blood pressure in the 
infarcted territory. None of the other parameters, as in- 
dicated in Tables II and III, showed a signilicant rela- 
tion to the scintigraphic tidings. 
DISCUSSION 
This study extends the preliminary findings of Walsh 
et all4 in that it investigates in more detail the relation 
between regional myocardial oxygen consumption as 
measured by C-11 acetate washout-rate constants and 
other clinical and investigative methods of assessing 
myocardial work in a larger group of patients after a 
TABLE II Linear Regression Analysis 
Dependent Variables 
C- 11 Acetate - C-l 1 Acetate- 
(k/min) lschemic (k/min) Remote 
Myocardium Myocardium 
r p Value r p Value 
Age of pt. - 0.5 0.26 0.1 - 
Sex 0.29 0.1 0.3 0.1 
Time to PET (days 0.26 0.13 0.22 0.3 
after MI) 
Time to thrombolysis 0.18 0.4 - 0.9 
(hr) (24 pts.) 
Time to PTCA (hr) - 0.5 0.8 
(23 pts.) 
Time to open vessel 0.42 0.048 - 0.15 
(22 pts.) 
Infarct location 0.411 0.021 0.2 0.35 
Double product 0.49 0.005 0.51 0.003 
(HR x SBP) 
Pre-PTCA stenosis % 0.4 0.5 
(24 pts.) 
C-11 = carbon-11; HR = heart rate; PET = position emission tomograph); 
Pre-PTCA = infarct vessel percent stenosis before percutaneous transluminal coronary 
angioplasty; SBP = systolic blood pressure; Time to open vessel = time to 
thrombolysrs if infarct vessel is patent at early catheterization just before PTCA, or time 
to PTCA if vessel is still occluded at PTCA. 
1 
TABLE Ill Stepwise Multiple Regression Analysis (dependent 
variable: k ischemic region) 1 
t Statistic p Value I 
0.016 
/issel Ipii7 o,oo6 1 0.043 
Time to open vessel = time to thrombolysis if infarct vessel is patent at early 
catheterization just before percutaneous transluminal coronary angiaplasty, or time to 
percutaneous transluminal coronary angioplasty if vessel is still occluded at percutane- 
ous transluminal coronary angioplasty. 
1 
myocardial infarction. It has shown the relatively loose 
association of regional C-11 acetate washout-rate con- 
stants with global estimates of regional myocardial oxy- 
gen consumption such as the rate-pressure product. It 
has also demonstrated for the tist time the effect of car- 
diac medications such as P-receptor blockers on region- 
al myocardial oxygen consumption. 
Carbo~ll acetate kinetics in the remote nomual 
myo-cerdium: Rate-pressure product shows excellent 
correlation with invasive measurements of global myo- 
cardial oxygen consumption in normal volunteers and 
patients with diffuse heart disease.15J6 However, the 
inherent limitation of the rate-pressure product as an 
estimate of either global or regional myocardial oxygen 
consumption in ischemic heart disease is suggested in 
the data obtained from the normal remote myocardium 
in the infarct patients. Although there was still a statis- 
tically significant correlation between C-11 washout-rate 
constants and the rate-pressure product, C-11 washout- 
rate constants in the remote normal myocardium of 
patients with myocardial infarction had substantially 
greater variability than those observed in normal volun- 
teers9,10,17 and those in patients with diffuse heart dis- 
easel8 over a similar range of rate-pressure products. 
These data suggest that a global predictor of myocardial 
oxygen demand is only likely to be closely related to 
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regional oxygen consumption when regional loading and 
perfusion are uniform throughout the heart. This is clear- 
ly not the case in ischemic heart disease. The lack of 
prediction of regional myocardial oxygen consumption 
by the rate-pressure product suggested by this study has 
direct implications in the design of studies evaluating the 
effect of drugs or other interventions on myocardial oxy- 
gen consumption in patients with coronary artery dis- 
ease. 
The lack of correlation between regional C-11 clear- 
ance in remote myocardium and the left ventricular ejec- 
tion fraction, another direct measure of ventricular dys- 
function, is also not surprising because of the latter’s rel- 
ative insensitivity to hemodynamic loading conditions. 
Thus, C-11 acetate kinetics are able to provide data on 
regional oxygen consumption that cannot really be eas- 
ily obtained by other noninvasive methods. 
EfFects of medications The value of assessment 
of regional myocardial oxygen consumption with C-11 
acetate and PET is best illustrated by the observations 
on the effect of B-receptor blocker therapy on regional 
C-11 acetate clearance soon after myocardial infarction. 
Beta blockade has been used in patients after myocardi- 
al infarction because of its ability to decrease long-term 
morbidity and mortality.19~20 The main action of B 
blockade is to inhibit sympathetic stimulation of the 
heart, thus reducing oxygen consumption. This is usual- 
ly manifest by reduction in heart rate and blood pres- 
sure as well as by indexes of myocardial contractility. In 
addition, metabolic effects of B blockade have been sug- 
gested which include increased carbohydrate use.*l This 
study has shown that in remote uninjured myocardium, 
B-receptor blocker therapy exerts an effect on regional 
myocardial oxygen consumption not confmed to a re- 
duction in rate-pressure product and possibly reflecting 
protection of the heart from increased levels of plasma 
catecholamines or decreased contractility. 
Interestingly, similar effects were not observed with 
other medications used in this patient group. This is not 
surprising for nitrates whose main effect is vasodilation, 
predominantly of the peripheral veins, reducing myocar- 
dial preload as well as improving flow to regions of 
myocardium beyond coronary stenoses. As such, it is not 
considered to have a direct effect on the contractile state 
of the heart.** The tinding of a lack of a significant effect 
on myocardial oxygen consumption by either calcium 
antagonists or angiotensin-converting enzyme inhibitors 
is also in keeping with their known effects of coronary 
and peripheral vasodilation.22,23 However, this linding 
needs to be interpreted with caution because the num- 
bers of patients taking these agents were small and var- 
ious subclasses of calcium antagonists were lumped 
together. Further studies are needed to expand these pre- 
liminary fmdings. 
Carbowll acetate kinetics in the infarcted 
myocardium: This study contirms the tindings of others 
that C-11 washout-rate constants are reduced in ischem- 
ically injured myocardium2~5J4 and, thus, supports the 
concept of reduced oxidative metabolism in such 
regions. It also raises the possibility of external work 
load requirements affecting myocardial oxygen con- 
sumption in these regions just as they appear to in the 
remote myocardium. There was a significant relation 
between myocardial work load and C-11 washout-rate 
constants in the infarct territory. The weak relation may 
be explained by the admixture of viable and necrotic tis- 
sue during the subacute phase of myocardial infarction. 
These data indicate that oxidative metabolism of injured 
myocardium is modified by overall ventricular work load 
despite the presence of regional wall motion abnormal- 
ities in the infarct territory. Since reduction of oxygen 
demand is thought to be beneficial in ischemically jeop- 
ardized myocardium, such measurements of regional 
oxidative metabolism may be helpful in pathophysio- 
logic and pharmacologic evaluation of acutely injured 
myocardium. Such measurements may reflect accurately 
the severity of ischemic damage as suggested by the 
significant relation between time of ischemia, prior 
thrombolysis, and C-11 washout rates deiined by multi- 
ple regression analysis (Tables II and Ill). Therefore, 
early metabolic evaluations of ischemically injured 
myocardium by C-11 acetate may provide information 
about tissue viability as recently suggested by Gropler 
et al’* in a small patient population. Further studies are 
required to compare C-11 acetate and t8F-2-deoxy-2- 
fluro-D-glucose in their role in predicting myocardial sal- 
vage after reperfusion therapy. 
However, the quantitative aspects of the analysis of 
C-11 tissue kinetics need to be interpreted with caution 
because the relation between C-11 washout-rate con- 
stants and actual oxidative metabolism is not as well 
established for regions with blood flow impairment and 
variable tissue viability as in myocardium with unre- 
stricted blood flow. Animal studies during acute ische- 
mia suggest a maintained relation of C-11 washout and 
oxygen consumption under such low flow conditions.24 
Preliminaty clinical data by Melin et al25 indicate that 
C-11 washout-rate constants are closely related to re- 
duced blood flow in the infarct territory. Because blood 
flow and oxygen consumption are closely coupled in 
normal and ischemic myocardium, separation of these 2 
physiologic parameters may be difficult. Future studies 
directly comparing regional blood flow and oxidative 
metabolism are needed to deline the diagnostic gain of 
the assessment of oxygen consumption over flow deter- 
mination alone for the deli&ion of tissue viability.26 
Conclusion: This study illustrates the unique poten- 
tial of regional C-11 washout-rate kinetics as an index 
of regional myocardial oxygen consumption in patients 
soon after myocardial infarction in clinical situations 
where there is a variable degree and extent of damaged 
myocardium. Regional assessment of myocardial oxygen 
consumption may assess the presence of viable myo- 
cardium early after reperfusion therapy. However, far- 
ther studies are required relating these metabolic mea- 
surements with long-term outcome of regional myocar- 
dial function. Besides the possible application of this 
technique in the management of patients with acute 
myocardial infarction, regional measurements of oxygen 
consumption will be useful in the characterization of 
pathophysiology and pharmacology during the subacute 
phase of the myocardial injury. Objective criteria of re- 
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gional oxygen consumption may be needed to optimize 
therapeutic strategies to reduce myocardial damage and 
to enhance tissue recovery. Using PET measurements, 
various drug regimens could be compared based on re- 
gional metabolic evaluation rather than on longitudinal 
studies assessing tissue recovery. Since PET remains an 
expensive technology, such a quantitative technique may 
be most useful in clinical research requiring end points 
for therapeutic interventions in patients with acute 
myocardial infarction. 
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